HAF prevents hepatocyte apoptosis and progression to MASH and HCC through transcriptional regulation of the NF-κB pathway
HAF is a novel transcriptional regulator of the NF-κB pathway and is a key determinant of cell fate during progression to MASH and MASH-HCC.
Authors
- Séverin Donald Kamdem (ORCID: https://orcid.org/0000-0003-0183-8078)
- Mei Yee Koh (ORCID: https://orcid.org/0000-0002-3241-7316)
- Scott A. Summers (ORCID: https://orcid.org/0000-0002-4919-0592)
- Po-An Hu
- Kimberley Evason (ORCID: https://orcid.org/0000-0002-0471-2473)
- Érika Said Abu Egal (ORCID: https://orcid.org/0000-0001-9429-6743)
- Yangsook Song Green (ORCID: https://orcid.org/0000-0003-3620-0971)
- Sydney A. McFarland
- Ryan M. O’Connell (ORCID: https://orcid.org/0000-0003-0860-1401)
- Martin Golkowski (ORCID: https://orcid.org/0000-0002-0996-1655)
- J. Alan Maschek (ORCID: https://orcid.org/0000-0003-3217-2299)
- Kathleen M. Maguire
- James E. Cox (ORCID: https://orcid.org/0000-0002-5977-2350)
- Patrice N. Mimche (ORCID: https://orcid.org/0000-0002-3761-7237)
- Amandine Chaix (ORCID: https://orcid.org/0000-0001-7007-197X)
- Warren P. Voth (ORCID: https://orcid.org/0000-0003-0632-6979)
- Gregory S. Ducker (ORCID: https://orcid.org/0000-0002-8651-6846)
- Karen Acuña-Pilarte
- Jordan W. Reelitz
- Ethan C. Reichert
- Lily M-T. Halberg
- Jillian Wright
Institutions
- University of Utah (US)
- Huntsman Cancer Institute (US)
Publication Details
- Journal
- Hepatology
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1097/hep.0000000000001070
- Citations
- 8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.09